T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COV
126
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $927M | 0.2% |
10,279,076
-217,982
| -2% | -$16.3M |
|
127
Cognizant
CTSH
$26.5B
| $923M | 0.2% |
18,866,131
-7,425,561
| -28% | -$362M |
|
128
Tesla
TSLA
$1.31T
| $921M | 0.2% |
57,570,495
-389,655
| -0.7% | -$5.43M |
|
|
HOT
129
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $913M | 0.2% |
11,298,302
-1,006,948
| -8% | -$79.2M |
|
|
IHS
130
DELISTED
IHS INC CL-A COM STK
IHS
| $913M | 0.2% |
6,729,812
+204,558
| +3% | +$25.5M |
|
131
Illinois Tool Works
ITW
$83.6B
| $904M | 0.2% |
10,322,340
+11,613
| +0.1% | +$998K |
|
132
AES
AES
$10.5B
| $903M | 0.2% |
58,045,638
-4,878,584
| -8% | -$70.1M |
|
133
Simon Property Group
SPG
$71.7B
| $885M | 0.19% |
5,325,124
-971,106
| -15% | -$159M |
|
|
XL
134
DELISTED
XL Group Ltd.
XL
| $873M | 0.19% |
26,666,080
-1,246,105
| -4% | -$40M |
|
|
TWX
135
DELISTED
Time Warner Inc
TWX
| $871M | 0.19% |
12,391,667
-2,017,225
| -14% | -$133M |
|
136
Estee Lauder
EL
$31.7B
| $870M | 0.19% |
11,716,290
+7,081,510
| +153% | +$520M |
|
137
Henry Schein
HSIC
$9.97B
| $858M | 0.19% |
18,444,173
+418,386
| +2% | +$19.1M |
|
138
Union Pacific
UNP
$174B
| $848M | 0.18% |
8,499,143
-3,699,549
| -30% | -$358M |
|
|
TWC
139
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $842M | 0.18% |
5,715,994
+248,472
| +5% | +$34.9M |
|
140
Ross Stores
ROST
$81.2B
| $830M | 0.18% |
25,088,868
+689,186
| +3% | +$23.7M |
|
141
Martin Marietta Materials
MLM
$33.2B
| $818M | 0.18% |
6,191,335
-170,275
| -3% | -$21.4M |
|
142
FirstEnergy
FE
$27.2B
| $817M | 0.18% |
23,526,808
+2,021,024
| +9% | +$68M |
|
143
Bristol-Myers Squibb
BMY
$130B
| $812M | 0.18% |
16,744,454
-909,460
| -5% | -$44.8M |
|
144
Alkermes
ALKS
$8.28B
| $812M | 0.18% |
16,128,089
-223,447
| -1% | -$10.3M |
|
|
ALTR
145
DELISTED
Altera Corp
ALTR
| $810M | 0.18% |
23,306,580
+5,762,610
| +33% | +$195M |
|
146
Charter Communications
CHTR
$18.9B
| $802M | 0.17% |
5,062,756
-955,328
| -16% | -$132M |
|
147
United Parcel Service
UPS
$88.8B
| $799M | 0.17% |
7,786,718
-184,864
| -2% | -$18.6M |
|
148
Liberty Global Class C
LBTYK
$3.4B
| $797M | 0.17% |
23,277,512
+9,582,016
| +70% | +$317M |
|
149
Comcast
CMCSA
$91B
| $793M | 0.17% |
29,545,682
+2,133,788
| +8% | +$54.8M |
|
150
Regeneron Pharmaceuticals
REGN
$83B
| $789M | 0.17% |
2,794,301
-1,308,589
| -32% | -$388M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.